ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $681,000 | -75.6% | 14,814 | -64.8% | 0.00% | -50.0% |
Q4 2021 | $2,794,000 | +61.8% | 42,092 | +52.2% | 0.00% | +100.0% |
Q3 2021 | $1,727,000 | -23.8% | 27,660 | +1.1% | 0.00% | -50.0% |
Q2 2021 | $2,265,000 | +1.1% | 27,351 | -19.1% | 0.00% | 0.0% |
Q1 2021 | $2,241,000 | -58.1% | 33,803 | -51.5% | 0.00% | -60.0% |
Q4 2020 | $5,352,000 | +931.2% | 69,735 | +479.1% | 0.01% | +400.0% |
Q3 2020 | $519,000 | +6.1% | 12,043 | +6.4% | 0.00% | 0.0% |
Q2 2020 | $489,000 | +60.3% | 11,315 | +6.9% | 0.00% | – |
Q1 2020 | $305,000 | -93.4% | 10,584 | -85.4% | 0.00% | -100.0% |
Q4 2019 | $4,609,000 | +251.0% | 72,659 | +56.0% | 0.00% | +300.0% |
Q3 2019 | $1,313,000 | -70.2% | 46,589 | -71.9% | 0.00% | -75.0% |
Q2 2019 | $4,401,000 | +14.3% | 166,089 | -20.8% | 0.00% | 0.0% |
Q1 2019 | $3,849,000 | +52.2% | 209,745 | +3.0% | 0.00% | +33.3% |
Q4 2018 | $2,529,000 | +48.7% | 203,613 | -55.9% | 0.00% | +200.0% |
Q4 2017 | $1,701,000 | -13.1% | 462,105 | +2.2% | 0.00% | -50.0% |
Q3 2017 | $1,958,000 | +11.9% | 452,120 | +89.9% | 0.00% | 0.0% |
Q3 2016 | $1,750,000 | – | 238,082 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |